Clinical Trial Update: Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)

View source ↗

Summary

Clinical trial update for tolterodine as part of a post-marketing commitment; study on overactive bladder completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Tolterodine (tolterodine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Overactive Bladder | Status: COMPLETED | Results posted: 2012-06-14